2025 annual financial data
Cumberland Pharmaceuticals Inc. 2025 Operating margin
Cumberland Pharmaceuticals Inc. 2025 operating margin with verified reported va…
Direct answer
Operating margin was -6.27%.
Operating income was -2,791,993 USD and net income was -2,836,128 USD.
Operating cash flow was 4,932,522 USD.
Get free Cumberland Pharmaceuticals Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 44,521,431 USD
- Operating income
- -2,791,993 USD
- Net income
- -2,836,128 USD
- Operating cash flow
- 4,932,522 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Cumberland Pharmaceuticals Inc. financial years